Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5774163 | 0.84 | — | — | |
| SCHEMBL14369404 | 0.73 | ESR1 (0.41) | SMN1; SMN2L3MBTL1EPHX2ESR1 | |
| SCHEMBL379399 | 0.72 | GAA (0.37) | GAAL3MBTL1 | |
| SCHEMBL4449961 | 0.70 | GAA (0.60) | GAAL3MBTL1 | |
| SCHEMBL2678629 | 0.70 | GAA (0.38) | GAAL3MBTL1 | |
| SCHEMBL8613670 | 0.69 | TSHR (0.43) | SMN1; SMN2L3MBTL1ESR1 | |
| SCHEMBL10574423 | 0.69 | TSHR (0.43) | SMN1; SMN2L3MBTL1ESR1 | |
| SCHEMBL9168096 | 0.69 | EPHX2 (0.31) | EPHX2 | |
| SCHEMBL28277841 | 0.68 | GAA (0.37) | GAAL3MBTL1 | |
| SCHEMBL16566503 | 0.68 | SPHK1 (0.33) | SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1681046-A2 | Cosmetic, pharmaceutical and dermatological compositions containing copolymer waxes | Clariant Produkte (Deutschland) GmbH (DE) | 2006-07-19 | — | — | EP | claimed |
| US-20060036013-A1 | Side-chain-modified copolymer waxes | HEINRICHS FRANZ-LEO | 2006-02-16 | — | — | US | claimed |
| CN-1659191-A | Side-chain-modified copolymer waxes | CLARIANT GMBH (DE) | 2005-08-24 | — | — | CN | claimed |
| EP-1523507-A1 | SIDE-CHAIN-MODIFIED COPOLYMER WAXES | Clariant GmbH (DE) | 2005-04-20 | — | — | EP | claimed |
| WO-2003104289-A1 | SIDE-CHAIN-MODIFIED COPOLYMER WAXES | CLARIANT GMBH (DE) | 2003-12-18 | — | — | WO | claimed |
| CN-1284803-C | Side-chain-modified copolymer waxes | CLARIANT GMBH (DE) | 2006-11-15 | — | — | CN | disclosed |
| EP-1681046-A2 | Cosmetic, pharmaceutical and dermatological compositions containing copolymer waxes | Clariant Produkte (Deutschland) GmbH (DE) | 2006-07-19 | — | — | EP | disclosed |
| US-20060104940-A1 | Cosmetic, pharmaceutical and dermatological preparations comprising copolymer waxes | CLARIANT GMBH | 2006-05-18 | — | — | US | disclosed |
| US-20060036013-A1 | Side-chain-modified copolymer waxes | HEINRICHS FRANZ-LEO | 2006-02-16 | — | — | US | disclosed |
| CN-1659191-A | Side-chain-modified copolymer waxes | CLARIANT GMBH (DE) | 2005-08-24 | — | — | CN | disclosed |
| EP-1523507-A1 | SIDE-CHAIN-MODIFIED COPOLYMER WAXES | Clariant GmbH (DE) | 2005-04-20 | — | — | EP | disclosed |
| WO-2003104289-A1 | SIDE-CHAIN-MODIFIED COPOLYMER WAXES | CLARIANT GMBH (DE) | 2003-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060104940-A1 | Cosmetic, pharmaceutical and dermatological preparations comprising copolymer waxes | CUTA, ACMSD, DEGS1 | SMN1; SMN2 3699/4885GAA 1124/4885L3MBTL1 4705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.